Novo Nordisk Pharmaceuticals (Philippines)

Last updated: 12.08.2015

novo_nordiskCompany description

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.

In the Philippines, Novo Nordisk started its operations in 1976 under the umbrella organization of its distributor. In 1999, steps were taken to establish an affiliate office in the Philippines with the vision of making Novo Nordisk a market leader in its areas of expertise. In June 30, 1999, the Philippine Office was finally able to obtain approval from the Securities and Exchange Commission to operate as an independent Pharmaceutical Company.

Products and services

We offer products and services in the following therapy areas: Diabetes Care, Coagulation management, Growth hormone therapy, and Hormone replacement therapy.

Contact details:

Address: 21st Floor Twenty Four Seven McKinley Bldg.

24th Street, corner 7th Avenue,

1634 Bonifacio Global City, Taguig City

Tel: +63 2 234 3500

Fax+632 234 3590




We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here